4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0000899243-16-021127
CIK 0001114220operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:15 PM ET
Size
7.1 KB
Accession
0000899243-16-021127
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Award
Common Stock
2016-05-26+10,000→ 160,000 total - Award
Stock Options (right to buy)
2016-05-26+30,000→ 30,000 totalExercise: $5.71From: 2017-05-26Exp: 2026-05-26→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of May 26, 2017, May 26, 2018 and May 26, 2019.
- [F2]Includes 31,666 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of May 26, 2017, May 26, 2018 and May 26, 2019.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:15 PM ET
- Size
- 7.1 KB